Medpace Holdings Inc buy Royal Bank of Canada
Start price
24.07.26
/
50%
€531.60
Target price
24.07.27
€608.13
Performance (%)
-3.84%
Price
29.07.26
€511.20
Summary
This prediction is currently active. With a performance of -3.84%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 24.07.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Medpace Holdings Inc | -3.84% |
| iShares Core DAX® | 1.014% |
| iShares Nasdaq 100 | -6.470% |
| iShares Nikkei 225® | -6.517% |
| iShares S&P 500 | -2.721% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Medpace Holdings Inc diskutieren
Medpace (MEDP) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $692.00 price target on the stock, up from $484.00.
Ratings data for MEDP provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Medpace Holdings Inc
Medpace Holdings Inc
Start price
Target price
Perf. (%)
€390.60
03.03.26
03.03.26
€446.26
03.03.27
03.03.27
30.88%
29.07.26
29.07.26
